MedPath

Anthisan Bite and Sting 2% w/w Cream

Marketing Authorization Holder: Phoenix Labs Unlimited Company, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, Co. Meath, Ireland.

Authorised
Legal Category

General Sales List

ATC Code

R06AC01

Authorization Number

PL 35104/0038

Summary of Product Characteristics

Detailed prescribing information and pharmaceutical guidance from the UK Electronic Medicines Compendium.

Composition

Active and inactive ingredients

Mepyramine Maleate 2% w/w Also contains: | | | | --- | --- | | Castor oil | 23,60% w/w | | Ceto-stearyl alcohol | 13,80% w/w | | Propylene glycol 600 monostearate | 4,90% w/w | | Methyl hydroxybenzoate | 0,20% w/w | For a full list of excipients, see section 6.1

Pharmaceutical Form

Dosage form and administration route

A smooth off-white cream

Clinical Particulars

Therapeutic indications and usage

4.1 Therapeutic indications Symptomatic relief of skin irritation caused by insect stings, insect bites and nettle stings. Route of Administration: Topical4.2 Posology and method of administration Adults, elderly and children over 2 years of age and older. Anthisan Bite and Sting Cream should be applied directly to the affected parts two or three times a day for up to three days. Early application is essential to obtain the optimum response.4.3 Contraindications Anthisan Bite and Sting Cream should not be used in eczematous conditions or on extensively broken skin surfaces, or if the skin is cut or grazed. Do not use on large areas of skin or on areas of sunburnt skin. Hypersensitivity to the active substance or to any of the excipients.4.4 Special warnings and precautions for use Repeated application of Anthisan Bite and Sting Cream to the same area for longer than three days is not recommended and treatment should be discontinued immediately if skin sensitisation occurs.4.5 Interaction with other medicinal products and other forms of interaction No significant interactions described.4.6 Pregnancy and lactation There is no evidence of the safety of mepyramine maleate in human pregnancy, but it has been widely used for many years without apparent ill consequence. Absorption of a significant amount after topical application is unlikely in the prescribed method of use, nevertheless, Anthisan Bite and Sting Cream should not be used during pregnancy or lactation, unless considered essential.4.7 Effects on ability to drive and use machines Anthisan Bite and Sting Cream has minor or moderate influence on the ability to drive and use machines. May theoretically be extensively absorbed through the skin when applied over large areas and cause somnolence and mild disorientation.4.8 Undesirable effects Skin sensitisation has been reported on rare occasions. **Reporting of suspected adverse reactions** Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.4.9 Overdose A 20g tube of Anthisan Bite and Sting Cream contains 400mg mepyramine maleate. If the product is ingested in significant amounts, this could be life-threatening in young children. The chief symptoms of overdosage is unconsciousness and there may be convulsions in the intervening periods. The stomach should be washed out. Stimuli liable to provoke convulsions should be avoided, but if this complication should occur, parenteral Diazepam should be given, sedatives which are liable to increase respiratory depression should be avoided. Other measures such as artificial respiration and oxygen may also be required and an antibiotic can be given as a prophylactic against pneumonia.

Pharmacological Properties

Pharmacodynamics and pharmacokinetics

5.1 Pharmacodynamic properties Pharmacotherapeutic group: Mepyramine maleate is an antihistamine with anti-pruritic and local analgesic actions. ATC code: Antihistamines for Topical Use R06AC015.2 Pharmacokinetic properties No pharmacokinetic data available by any route of administration.5.3 Preclinical safety data There are no findings of relevance to the prescriber, additional to those already included in other sections of the SPC.

Pharmaceutical Particulars

Storage and handling information

6.1 List of excipients Ceto-stearyl alcohol Polyethylene glycol 600 monostearate Castor oil Methyl hydroxybenzoate Foin coupe (fragrance) Silicone antifoam Purified water6.2 Incompatibilities Not applicable6.3 Shelf life 3 years6.4 Special precautions for storage Do not store above 30° C.6.5 Nature and contents of container Collapsible aluminium tube with extended nozzle and polyethylene screw cap containing 20g cream.6.6 Special precautions for disposal and other handling No special requirements.

Last updated: 30/06/2023

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.